English | Español

Regulatory
+ Regulatory
John Breslin | Jun 15, 2017

Speculation that Senate health care bill will differ wildly from House version may be overstated
+ Regulatory
Cheyenne Dickerson | Jun 14, 2017

Cancer survivors, supporters urge New York City to enact stricter tobacco laws
+ Regulatory
Cheyenne Dickerson | Jun 13, 2017

U.S. targeting $70 million to fight opioid addiction
+ Regulatory
Michael McGrady | Jun 12, 2017

Federal agencies continue to implement National Pain Strategy over one year later
+ Regulatory
Nicholas Gueguen | Jun 11, 2017

European Commission OKs Spinraza to fight spinal muscular atrophy
+ Regulatory
Robert Hadley | Jun 11, 2017

GlaxoSmithKline submits single-tablet, dual-drug HIV regimen for FDA approval
+ Regulatory
Ruth de Jauregui | Jun 8, 2017

BioMarin's Brineura gets European approval for treating CLN2 brain disease in children
+ Regulatory
Ruth de Jauregui | Jun 8, 2017

Anthem leaving Ohio health insurance exchange

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes